EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.054
March 31, 2026 -1.382
December 31, 2025 -1.232
September 30, 2025 -3.483
June 30, 2025 -5.962
March 31, 2025 -6.331
December 31, 2024 -5.790
September 30, 2024 -4.314
June 30, 2024 -4.599
March 31, 2024 -5.552
December 31, 2023 -8.239
September 30, 2023 -9.440
June 30, 2023 -9.795
March 31, 2023 -9.738
Date Value
December 31, 2022 -9.797
September 30, 2022 -10.78
June 30, 2022 -11.11
March 31, 2022 -12.66
December 31, 2021 -12.47
September 30, 2021 -11.25
June 30, 2021 -10.76
March 31, 2021 -9.073
December 31, 2020 -16.34
September 30, 2020 -15.89
June 30, 2020 -13.66
March 31, 2020 -11.75
December 31, 2019 -2.185

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Autolus Therapeutics Plc -1.050
DBV Technologies SA -3.514
Cellectis SA -0.6502
Akari Therapeutics Plc -19.78
Ascendis Pharma A/S 13.12